Thermo Fisher Scientific Acquisitions remained flat by 0.0% to $1.01B in Q4 2025 compared to the prior quarter. Over 4 years (FY 2021 to FY 2025), Acquisitions shows a downward trend with a -32.5% CAGR.
Large outflows indicate a period of aggressive expansion and consolidation, which carries integration risk but potential for high growth.
The net cash paid to acquire other businesses, calculated as the purchase price minus any cash already held by the targe...
Lumpy and episodic across the semiconductor industry, often occurring in cycles of industry consolidation.
cf_acquisitions| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $82.00M | $94.00M | $17.88B | $40.00M | $0.00 | -$1.00M | $0.00 | $2.70B | $47.00M | $909.00M | $0.00 | $0.00 | $0.00 | $3.13B | $0.00 | $1.01B | $1.01B | $1.01B | $1.01B |
| QoQ Change | — | +14.6% | >999% | -99.8% | -100.0% | — | +100.0% | — | -98.3% | >999% | -100.0% | — | — | — | -100.0% | — | +0.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | — | -100.0% | -101.1% | -100.0% | >999% | — | >999% | — | -100.0% | -100.0% | +244.6% | — | — | — | -67.8% | — |
We use cookies for analytics. See our Privacy and Cookie Policy.